Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Filings indexed 1,625 across all filing types
Latest filing 2013-12-31 Regulatory Filings
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
UPDATED DEVELOPMENT ON TIANJIN TIANXIAO PROJECT
Regulatory Filings Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding an update on the Tianjin Tianxiao Project. It references previous announcements and an interim report but does not contain any financial statements or detailed financial data itself. The document is relatively short (2605 characters) and primarily provides a status update on a project development and contractual issues with a vendor. It also states that further announcements will be made as required by the stock exchange rules. There is no indication that this is a full report, audit, or financial statement. It is clearly an announcement about a project development status, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2013-12-31 English
List of Directors and their Role and Function
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles, including details about board committees such as Audit, Nomination, and Remuneration Committees. It is a clear announcement of the composition and structure of the company's board and its committees. There is no financial data, no report attached or referenced, and no mention of voting results or other meeting materials. This fits the definition of Board/Management Information (MANG), which covers announcements of changes or details about the company's board of directors or senior management.
2013-12-11 English
CONTINUING CONNECTED TRANSACTIONS AND CHANGE OF NON-EXECUTIVE DIRECTOR AND BOARD COMMITTEE MEMBER
Board/Management Information Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding continuing connected transactions and changes in non-executive director and board committee membership. It details multiple agreements entered into on 11 December 2013 involving connected parties, with descriptions of the transactions, annual caps, and reasons for the transactions. It also announces the resignation and appointment of non-executive directors and committee members. The content focuses on corporate governance changes and connected transactions disclosures, typical of board/management announcements. There is no indication of full financial statements, quarterly or annual financial results, or audit reports. The document is not a report itself but an announcement of transactions and board changes. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (15,000 characters) and detailed content support a high confidence in this classification.
2013-12-11 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 30 November 2013
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2013, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content is focused on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance report rather than a financial report or announcement. The document length is about 14,567 characters, indicating it is a full report rather than a brief announcement. Given the nature of the content and the regulatory submission context, this fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other specific categories like capital changes (SHA) or director dealings (DIRS). It is not a capital/financing update (CAP) because it does not discuss fundraising or financing activities, only share capital movements. It is not a share issue/capital change (SHA) because it covers a broad range of share capital movements including options and warrants, not just new share issues. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2013-12-03 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 October 2013
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2013, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content is focused on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month. The document length is about 14,567 characters, indicating a detailed report rather than a brief announcement. This type of document fits best under 'Regulatory Filings' (RNS) as it is a compliance report to the exchange about share capital movements and does not fit other categories like capital/financing update (which would be more about fundraising), earnings release, or annual/interim reports.
2013-11-01 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 30 September 2013
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/09/2013, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content is focused on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance report rather than a financial report or announcement of a report. The document length is over 14,000 characters and contains detailed data, not just an announcement or certification. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about share capital movements that does not fit other more specific categories like Share Issue/Capital Change (SHA) because it covers a broad range of share capital movements and is a monthly return filing to the exchange.
2013-10-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.